Gaither Julie R, Leventhal John M, Ryan Sheryl A, Camenga Deepa R
Department of Epidemiology and Public Health, Yale School of Medicine, New Haven, Connecticut2Yale Center for Medical Informatics, Yale School of Medicine, New Haven, Connecticut3Biomedical Informatics/Research Service, Veterans Affairs Connecticut Healthcare System, Department of Veterans Affairs, West Haven, Connecticut.
Department of Pediatrics, Yale School of Medicine, New Haven, Connecticut.
JAMA Pediatr. 2016 Dec 1;170(12):1195-1201. doi: 10.1001/jamapediatrics.2016.2154.
National data show a parallel relationship between recent trends in opioid prescribing practices and hospitalizations for opioid poisonings in adults. No similar estimates exist describing hospitalizations for opioid poisonings in children and adolescents.
To describe the incidence and characteristics of hospitalizations attributed to opioid poisonings in children and adolescents.
DESIGN, SETTING, AND PARTICIPANTS: Retrospective analysis of serial cross-sectional data from a nationally representative sample of US pediatric hospital discharge records collected every 3 years from January 1, 1997, through December 31, 2012. The Kids' Inpatient Database was used to identify 13 052 discharge records for patients aged 1 to 19 years who were hospitalized for opioid poisonings. Data were analyzed within the collection time frame.
Poisonings attributed to prescription opioids were identified by codes from the International Classification of Diseases, Ninth Revision, Clinical Modification. In adolescents aged 15 to 19 years, poisonings attributed to heroin were also identified. Census estimates were used to calculate incidence per 100 000 population. The Cochran-Armitage test for trend was used to assess for changes in incidence over time.
From 1997 to 2012, a total of 13 052 (95% CI, 12 500-13 604) hospitalizations for prescription opioid poisonings were identified. The annual incidence of hospitalizations for opioid poisonings per 100 000 children aged 1 to 19 years rose from 1.40 (95% CI, 1.24-1.56) to 3.71 (95% CI, 3.44-3.98), an increase of 165% (P for trend, <.001). Among children 1 to 4 years of age, the incidence increased from 0.86 (95% CI, 0.60-1.12) to 2.62 (95% CI, 2.17-3.08), an increase of 205% (P for trend, <.001). For adolescents aged 15 to 19 years, the incidence increased from 3.69 (95% CI, 3.20-4.17) to 10.17 (95% CI, 9.48-10.85), an increase of 176% (P for trend, <.001). In this age group, poisonings from heroin increased from 0.96 (95% CI, 0.75-1.18) to 2.51 (95% CI, 2.21-2.80), an increase of 161% (P for trend, <.001); poisonings involving methadone increased from 0.10 (95% CI, 0.03-0.16) to 1.05 (95% CI, 0.87-1.23), an increase of 950% (P for trend, <.001).
During the course of 16 years, hospitalizations attributed to opioid poisonings rose nearly 2-fold in the pediatric population. Hospitalizations increased across all age groups, yet young children and older adolescents were most vulnerable to the risks of opioid exposure. Mitigating these risks will require comprehensive strategies that target opioid storage, packaging, and misuse.
国家数据显示,成人阿片类药物处方行为的近期趋势与阿片类药物中毒住院治疗之间存在平行关系。目前尚无类似的估计描述儿童和青少年阿片类药物中毒的住院情况。
描述儿童和青少年阿片类药物中毒住院的发生率及特征。
设计、设置和参与者:对1997年1月1日至2012年12月31日期间每3年收集一次的具有全国代表性的美国儿科医院出院记录样本的系列横断面数据进行回顾性分析。使用儿童住院数据库识别13052份1至19岁因阿片类药物中毒住院患者的出院记录。在收集时间范围内对数据进行分析。
根据《国际疾病分类,第九版,临床修订本》的编码识别处方阿片类药物所致中毒。在15至19岁的青少年中,还识别出海洛因所致中毒。使用人口普查估计数计算每10万人口中的发病率。采用趋势Cochran-Armitage检验评估发病率随时间的变化。
1997年至2012年,共识别出13052例(95%CI,12500 - 13604)处方阿片类药物中毒住院病例。每10万1至19岁儿童阿片类药物中毒住院的年发病率从1.40(95%CI,1.24 - 1.56)升至3.71(95%CI,3.44 - 3.98),增长了165%(趋势P值,<.001)。在1至4岁儿童中,发病率从0.86(95%CI,0.60 - 1.12)升至2.62(95%CI,2.17 - 3.08),增长了205%(趋势P值,<.001)。对于15至19岁的青少年,发病率从3.69(95%CI,3.20 - 4.17)升至10.17(95%CI,9.48 - 10.85),增长了176%(趋势P值,<.001)。在该年龄组中,海洛因中毒从0.96(95%CI,0.75 - 1.18)升至2.51(95%CI,2.21 - 2.80),增长了161%(趋势P值,<.001);美沙酮中毒从0.10(95%CI,0.03 - 0.16)升至1.05(95%CI,0.87 - 1.23),增长了950%(趋势P值,<.001)。
在16年期间,儿科人群中阿片类药物中毒住院病例增加了近两倍。所有年龄组的住院病例均有所增加,但幼儿和大龄青少年最易遭受阿片类药物暴露风险。减轻这些风险需要针对阿片类药物储存、包装和滥用的综合策略。